New medication for sleep disorders to enter phase 3 clinical trial in United States, reports The Korea Herald.
The third step of the clinical trial, which will be led by Jazz Pharmaceuticals, U.S. drugmaker and SK Biopharmaceuticals’ partner, will take place in the U.S. and Europe with patients suffering from narcolepsy and sleep apnea, the Korean company said.
